Vaccine adverse event reporting system VAERS | What to expect after getting a COVID-19 vaccine |
---|---|
Centers for Disease Control and Prevention | Centers for Disease Control and Prevention |
Frequently asked questions about COVID-19 vaccination.
19mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-Cov-2 variants | Phased allocation of COVID-19 vaccines |
---|---|
V-safe after vaccination health checker | FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine |
COVID-19 vaccine: Frequently asked questions.
18Use of Pfizer-BioNTech COVID-19 vaccine: Clinical considerations | Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States |
---|---|
When vaccine is limited, who should get vaccinated first? Vaccination considerations for persons with underlying medication conditions |
Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera.
13